The intraperitoneal administration of 4F peptide reduces early nascent atherosclerosis in Apoe-/- and Ldlr-/- mice (Navab et al., 2002; Wool et al., 2011) but has little effect on mature lesions in 28 week old animals (Wool et al., 2011). The gene discussed is APOE; the disease is atherosclerosis.